|
1
|
Kumar V, Ramnarayanan K, Sundar R,
Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK,
Tay ST, et al: Single-cell atlas of lineage states, tumor
microenvironment, and subtype-specific expression programs in
gastric cancer. Cancer Discov. 12:670–691. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yasuda T and Wang YA: Gastric cancer
immunosuppressive microenvironment heterogeneity: Implications for
therapy development. Trends Cancer. 10:627–642. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Y, Yin J, Zhao L, Zhou G, Dong S,
Zhang Y, Niu P, Ren H, Zheng T, Yan J, et al: Reconstruction of the
gastric cancer microenvironment after neoadjuvant chemotherapy by
longitudinal single-cell sequencing. J Transl Med. 20:5632022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zu M, Hao X, Ning J, Zhou X, Gong Y, Lang
Y, Xu W, Zhang J and Ding S: Patient-derived organoid culture of
gastric cancer for disease modeling and drug sensitivity testing.
Biomed Pharmacother. 163:1147512023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo M, Hu P, Xie J, Tang K, Hu S, Sun J,
He Y, Li J, Lu W, Liu H, et al: Remodeling the immune
microenvironment for gastric cancer therapy through antagonism of
prostaglandin E2 receptor 4. Genes Dis. 11:1011642023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun H, Wang X, Wang X, Xu M and Sheng W:
The role of cancer-associated fibroblasts in tumorigenesis of
gastric cancer. Cell Death Dis. 13:8742022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shaopeng Z, Yang Z, Yuan F, Chen H and
Zhengjun Q: Regulation of regulatory T cells and tumor-associated
macrophages in gastric cancer tumor microenvironment. Cancer Med.
13:e69592024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsieh HL and Tsai MM: Tumor
progression-dependent angiogenesis in gastric cancer and its
potential application. World J Gastrointest Oncol. 11:686–704.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moreira AM, Pereira J, Melo S, Fernandes
MS, Carneiro P, Seruca R and Figueiredo J: The extracellular
matrix: An accomplice in gastric cancer development and
progression. Cells. 9:3942020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang F, Zhang T, Li Q, Chen X, Jiang F and
Shen X: The tumor immune-microenvironment in gastric cancer.
Tumori. 108:541–551. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Li C, Lu Y, Liu C and Yang W: Tumor
microenvironment-mediated immune tolerance in development and
treatment of gastric cancer. Front Immunol. 13:10168172022.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Meng WJ and Wang ZQ: Cancer stem
cells and the tumor microenvironment in gastric cancer. Front
Oncol. 11:8039742022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Yuan Q, Guo H, Guan H, Hong Z and
Shang D: Deciphering drug resistance in gastric cancer: Potential
mechanisms and future perspectives. Biomed Pharmacother.
173:1163102024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rojas A, Araya P, Gonzalez I and Morales
E: Gastric tumor microenvironment. Adv Exp Med Biol. 1226:23–35.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fiori ME, Di Franco S, Villanova L, Bianca
P, Stassi G and De Maria R: Cancer-associated fibroblasts as
abettors of tumor progression at the crossroads of EMT and therapy
resistance. Mol Cancer. 18:702019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kobayashi H, Enomoto A, Woods SL, Burt AD,
Takahashi M and Worthley DL: Cancer-associated fibroblasts in
gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 16:282–295.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helms E, Onate MK and Sherman MH:
Fibroblast heterogeneity in the pancreatic tumor microenvironment.
Cancer Discov. 10:648–656. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu
J, Liang C, Hua J, Zhao Y, Yu X and Shi S: Signaling pathways in
cancer-associated fibroblasts: Recent advances and future
perspectives. Cancer Commun (Lond). 43:3–41. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan J, Xiao G, Yang C, Liu Q, Lv C, Yu X,
Zhou Z, Lin S, Bai Z, Lin H, et al: Cancer-associated fibroblasts
promote lymphatic metastasis in cholangiocarcinoma via the
PDGF-BB/PDGFR-β mediated paracrine signaling network. Aging Dis.
15:369–389. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kinoshita H, Yashiro M, Fukuoka T,
Hasegawa T, Morisaki T, Kasashima H, Masuda G, Noda S and Hirakawa
K: Diffuse-type gastric cancer cells switch their driver pathways
from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor
microenvironments. Carcinogenesis. 36:1511–1520. 2015.PubMed/NCBI
|
|
23
|
Lou M, Iwatsuki M, Wu X, Zhang W,
Matsumoto C and Baba H: Cancer-associated fibroblast-derived IL-8
upregulates PD-L1 expression in gastric cancer through the NF-κB
pathway. Ann Surg Oncol. 31:2983–2995. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galbo PM Jr, Zang X and Zheng D: Molecular
features of cancer-associated fibroblast subtypes and their
implication on cancer pathogenesis, prognosis, and immunotherapy
resistance. Clin Cancer Res. 27:2636–2647. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto Y, Kasashima H, Fukui Y, Tsujio
G, Yashiro M and Maeda K: The heterogeneity of cancer-associated
fibroblast subpopulations: Their origins, biomarkers, and roles in
the tumor microenvironment. Cancer Sci. 114:16–24. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q and Peng C: Cancer-associated
fibroblasts regulate the biological behavior of cancer cells and
stroma in gastric cancer. Oncol Lett. 15:691–698. 2018.PubMed/NCBI
|
|
27
|
Lin Y, Pan X, Zhao L, Yang C, Zhang Z,
Wang B, Gao Z, Jiang K, Ye Y, Wang S and Shen Z: Immune cell
infiltration signatures identified molecular subtypes and
underlying mechanisms in gastric cancer. NPJ Genom Med. 6:832021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gambardella V, Castillo J, Tarazona N,
Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló
S, Roda D, Huerta M, Cervantes A and Fleitas T: The role of
tumor-associated macrophages in gastric cancer development and
their potential as a therapeutic target. Cancer Treat Rev.
86:1020152020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang G, Gao Z, Guo X, Ma R, Wang X, Zhou
P, Li C, Tang Z, Zhao R and Gao P: CAP2 promotes gastric cancer
metastasis by mediating the interaction between tumor cells and
tumor-associated macrophages. J Clin Invest. 133:e1662242023.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miao L, Qi J, Zhao Q, Wu QN, Wei DL, Wei
XL, Liu J, Chen J, Zeng ZL, Ju HQ, et al: Targeting the STING
pathway in tumor-associated macrophages regulates innate immune
sensing of gastric cancer cells. Theranostics. 10:498–515. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ivanović T, Božić D, Benzon B, Čapkun V,
Vukojević K and Glavina Durdov M: Histological type, cytotoxic T
cells and macrophages in the tumor microenvironment affect the
PD-L1 status of gastric cancer. Biomedicines. 11:7092023.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu HT, Ai X, Lu M, Song Z and Li H:
Characterization of intratumoral and circulating IL-10-producing B
cells in gastric cancer. Exp Cell Res. 384:1116522019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu Y, Wang X, Bai S, Niu L, Zhao G, Yao Y,
Li B and Li H: The effects of TNF-α/TNFR2 in regulatory T cells on
the microenvironment and progression of gastric cancer. Int J
Cancer. 150:1373–1391. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mesali H, Ajami A, Hussein-Nattaj H,
Rafiei A, Rajabian Z, Asgarian-Omran H, Hosseini V, Taghvaei T and
Tehrani M: Regulatory T cells and myeloid-derived suppressor cells
in patients with peptic ulcer and gastric cancer. Iran J Immunol.
13:167–177. 2016.PubMed/NCBI
|
|
35
|
Tsutsumi C, Ohuchida K, Katayama N, Yamada
Y, Nakamura S, Okuda S, Otsubo Y, Iwamoto C, Torata N, Horioka K,
et al: Tumor-infiltrating monocytic myeloid-derived suppressor
cells contribute to the development of an immunosuppressive tumor
microenvironment in gastric cancer. Gastric Cancer. 27:248–262.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang X, Shi H, Yuan X, Jiang P, Qian H
and Xu W: Tumor-derived exosomes induce N2 polarization of
neutrophils to promote gastric cancer cell migration. Mol Cancer.
17:1462018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Weygant N, Ge Y, Westphalen CB, Ma WW and
Vega KJ: Role of the microenvironment in gastrointestinal tumors. J
Oncol. 2019:21534132019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo Q, Dong Z, Xie W, Fu X, Lin L, Zeng Q,
Chen Y, Ye G, Chen M, Hu H, et al: Apatinib remodels the
immunosuppressive tumor ecosystem of gastric cancer enhancing
anti-PD-1 immunotherapy. Cell Rep. 42:1124372023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Oh DY, Doi T, Shirao K, Lee KW, Park SR,
Chen Y, Yang L, Valota O and Bang YJ: Phase I study of axitinib in
combination with cisplatin and capecitabine in patients with
previously untreated advanced gastric cancer. Cancer Res Treat.
47:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen J, Guo J, Chen Z, Wang J, Liu M and
Pang X: Linifanib (ABT-869) potentiates the efficacy of
chemotherapeutic agents through the suppression of receptor
tyrosine kinase-mediated AKT/mTOR signaling pathways in gastric
cancer. Sci Rep. 6:293822016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ryu MH, Lee KH, Shen L, Yeh KH, Yoo C,
Hong YS, Park YI, Yang SH, Shin DB, Zang DY, et al: Randomized
phase II study of capecitabine plus cisplatin with or without
sorafenib in patients with metastatic gastric cancer (STARGATE).
Cancer Med. 12:7784–7794. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Giubelan A, Stancu MI, Honţaru SO,
Mălăescu GD, Badea-Voiculescu O, Firoiu C and Mogoantă SŞ: Tumor
angiogenesis in gastric cancer. Rom J Morphol Embryol. 64:311–318.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng Y, Dai Y, Gong Z, Cheng JN, Zhang L,
Sun C, Zeng X, Jia Q and Zhu B: Association between angiogenesis
and cytotoxic signatures in the tumor microenvironment of gastric
cancer. Onco Targets Ther. 11:2725–2733. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brzozowa M, Michalski M, Harabin-Słowińska
M and Wojnicz R: The role of tumour microenvironment in gastric
cancer angiogenesis. Prz Gastroenterol. 9:325–328. 2014.PubMed/NCBI
|
|
45
|
Liu P, Ding P, Sun C, Chen S, Lowe S, Meng
L and Zhao Q: Lymphangiogenesis in gastric cancer: Function and
mechanism. Eur J Med Res. 28:4052023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang Z, Xue F, Li M, Zhu X, Lu X, Wang C,
Xu E, Wang X, Zhang L, Yu H, et al: Extracellular matrix
characterization in gastric cancer helps to predict prognosis and
chemotherapy response. Front Oncol. 11:7533302021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moreira AM, Ferreira RM, Carneiro P,
Figueiredo J, Osório H, Barbosa J, Preto J, Pinto-do-Ó P, Carneiro
F and Seruca R: Proteomic identification of a gastric tumor ECM
signature associated with cancer progression. Front Mol Biosci.
9:8185522022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi
M, Bin J, Liao Y, Rao J and Liao W: Tumor microenvironment
characterization in gastric cancer identifies prognostic and
immunotherapeutically relevant gene signatures. Cancer Immunol Res.
7:737–750. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xia X, Wang S, Ni B, Xing S, Cao H, Zhang
Z, Yu F, Zhao E and Zhao G: Hypoxic gastric cancer-derived exosomes
promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α
positive feedback loop. Oncogene. 39:6231–6244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Oya Y, Hayakawa Y and Koike K: Tumor
microenvironment in gastric cancers. Cancer Sci. 111:2696–2707.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhou Z and Lu ZR: Molecular imaging of the
tumor microenvironment. Adv Drug Deliv Rev. 113:24–48. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
van Dam S, Baars MJD and Vercoulen Y:
Multiplex tissue imaging: Spatial revelations in the tumor
microenvironment. Cancers (Basel). 14:31702022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jiang Y, Wang H, Wu J, Chen C, Yuan Q,
Huang W, Li T, Xi S, Hu Y, Zhou Z, et al: Noninvasive imaging
evaluation of tumor immune microenvironment to predict outcomes in
gastric cancer. Ann Oncol. 31:760–768. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Guo J, Wang B, Fu Z, Wei J and Lu W:
Hypoxic microenvironment induces EMT and upgrades stem-like
properties of gastric cancer cells. Technol Cancer Res Treat.
15:60–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang B, Song B, Li Y, Zhao Q and Tan B:
Mapping spatial heterogeneity in gastric cancer microenvironment.
Biomed Pharmacother. 172:1163172024. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
57
|
Koda T, Matsushima S, Sasaki A, Danjo Y
and Kakinuma M: c-myc Gene amplification in primary stomach cancer.
Jpn J Cancer Res. 76:551–554. 1985.PubMed/NCBI
|
|
58
|
Cai HQ, Zhang LY, Fu LM, Xu B and Jiao Y:
Mutational landscape of TP53 and CDH1 in gastric cancer. World J
Gastrointest Surg. 16:276–283. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
De Marco K, Sanese P, Simone C and Grossi
V: Histone and DNA methylation as epigenetic regulators of DNA
damage repair in gastric cancer and emerging therapeutic
opportunities. Cancers (Basel). 15:49762023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Katoh M: Multi-layered prevention and
treatment of chronic inflammation, organ fibrosis and cancer
associated with canonical WNT/β-catenin signaling activation
(Review). Int J Mol Med. 42:713–725. 2018.PubMed/NCBI
|
|
61
|
Fattahi S, Amjadi-Moheb F, Tabaripour R,
Ashrafi GH and Akhavan-Niaki H: PI3K/AKT/mTOR signaling in gastric
cancer: Epigenetics and beyond. Life Sci. 262:1185132020.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Magnelli L, Schiavone N, Staderini F,
Biagioni A and Papucci L: MAP kinases pathways in gastric cancer.
Int J Mol Sci. 21:28932020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zheng L, Xu C, Guan Z, Su X, Xu Z, Cao J
and Teng L: Galectin-1 mediates TGF-β-induced transformation from
normal fibroblasts into carcinoma-associated fibroblasts and
promotes tumor progression in gastric cancer. Am J Transl Res.
8:1641–1658. 2016.PubMed/NCBI
|
|
64
|
Hasegawa T, Yashiro M, Nishii T, Matsuoka
J, Fuyuhiro Y, Morisaki T, Fukuoka T, Shimizu K, Shimizu T, Miwa A
and Hirakawa K: Cancer-associated fibroblasts might sustain the
stemness of scirrhous gastric cancer cells via transforming growth
factor-β signaling. Int J Cancer. 134:1785–1795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi
M, Yu Y, Zhu Z and Zhang J: HGF-mediated crosstalk between
cancer-associated fibroblasts and MET-unamplified gastric cancer
cells activates coordinated tumorigenesis and metastasis. Cell
Death Dis. 9:8672018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hong HN, Won YJ, Shim JH, Kim HJ, Han SH,
Kim BS and Kim HS: Cancer-associated fibroblasts promote gastric
tumorigenesis through EphA2 activation in a ligand-independent
manner. J Cancer Res Clin Oncol. 144:1649–1663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu R, Li B, Zi J, Zhang R, Yu M, Zhou J,
Pu Y and Xiong W: The dual role of LOXL4 in the pathogenesis and
development of human malignant tumors: A narrative review. Transl
Cancer Res. 13:2026–2042. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bin YL, Hu HS, Tian F, Wen ZH, Yang MF, Wu
BH, Wang LS, Yao J and Li DF: Metabolic reprogramming in gastric
cancer: Trojan horse effect. Front Oncol. 11:7452092022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Nienhüser H and Schmidt T: Angiogenesis
and anti-angiogenic therapy in gastric cancer. Int J Mol Sci.
19:432017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chen J, Zhang M, Ma Z, Yuan D, Zhu J, Tuo
B, Li T and Liu X: Alteration and dysfunction of ion
channels/transporters in a hypoxic microenvironment results in the
development and progression of gastric cancer. Cell Oncol (Dordr).
44:739–749. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hao LS, Liu Q, Tian C, Zhang DX, Wang B,
Zhou DX, Li ZP and Yuan ZX: Correlation and expression analysis of
hypoxia-inducible factor 1α, glucose transporter 1 and lactate
dehydrogenase 5 in human gastric cancer. Oncol Lett. 18:1431–1441.
2019.PubMed/NCBI
|
|
72
|
Shang Z, Ma Z, Wu E, Chen X, Tuo B, Li T
and Liu X: Effect of metabolic reprogramming on the immune
microenvironment in gastric cancer. Biomed Pharmacother.
170:1160302024. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ham IH, Lee D and Hur H: Role of
cancer-associated fibroblast in gastric cancer progression and
resistance to treatments. J Oncol. 2019:62707842019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Taeb S, Ashrafizadeh M, Zarrabi A,
Rezapoor S, Musa AE, Farhood B and Najafi M: Role of tumor
microenvironment in cancer stem cells resistance to radiotherapy.
Curr Cancer Drug Targets. 22:18–30. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Andreuzzi E, Capuano A, Poletto E, Pivetta
E, Fejza A, Favero A, Doliana R, Cannizzaro R, Spessotto P and
Mongiat M: Role of extracellular matrix in gastrointestinal
cancer-associated angiogenesis. Int J Mol Sci. 21:36862020.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang N, Cao M, Duan Y, Bai H, Li X and
Wang Y: Prognostic role of tumor-infiltrating lymphocytes in
gastric cancer: A meta-analysis and experimental validation. Arch
Med Sci. 16:1092–1103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ding X, Xi W, Ji J, Cai Q, Jiang J, Shi M,
Yu Y, Zhu Z and Zhang J: HGF derived from cancer-associated
fibroblasts promotes vascularization in gastric cancer via PI3K/AKT
and ERK1/2 signaling. Oncol Rep. 40:1185–1195. 2018.PubMed/NCBI
|
|
78
|
Wan X, Guan S, Hou Y, Qin Y, Zeng H, Yang
L, Qiao Y, Liu S, Li Q, Jin T, et al: FOSL2 promotes
VEGF-independent angiogenesis by transcriptionnally activating
Wnt5a in breast cancer-associated fibroblasts. Theranostics.
11:4975–4991. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yoshida CJ: Regulation of heterogeneous
cancer-associated fibroblasts: The molecular pathology of activated
signaling pathways. J Exp Clin Cancer Res. 39:1122020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Huang J, Zhang L, Wan D, Zhou L, Zheng S,
Lin S and Qiao Y: Extracellular matrix and its therapeutic
potential for cancer treatment. Signal Transduct Target Ther.
6:1532021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ilan N, Elkin M and Vlodavsky I:
Regulation, function and clinical significance of heparanase in
cancer metastasis and angiogenesis. Int J Biochem Cell Biol.
38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Fan HL, Han ZT, Gong XR, Wu YQ, Fu YJ, Zhu
TM and Li H: Macrophages in CRSwNP: Do they deserve more attention?
Int Immunopharmacol. 134:1122362024. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Xu Y, Miller CP, Tykodi SS, Akilesh S and
Warren EH: Signaling crosstalk between tumor endothelial cells and
immune cells in the microenvironment of solid tumors. Front Cell
Dev Biol. 12:13871982024. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wang K, Zhao XH, Liu J, Zhang R and Li JP:
Nervous system and gastric cancer. Biochim Biophys Acta Rev Cancer.
1873:1883132020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sukri A, Hanafiah A and Kosai NR: The
roles of immune cells in gastric cancer: Anti-cancer or pro-cancer?
Cancers (Basel). 14:39222022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Xu X, Chen J, Li W, Feng C, Liu Q, Gao W
and He M: Immunology and immunotherapy in gastric cancer. Clin Exp
Med. 23:3189–3204. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tong L, Jiménez-Cortegana C, Tay AHM,
Wickström S, Galluzzi L and Lundqvist A: NK cells and solid tumors:
Therapeutic potential and persisting obstacles. Mol Cancer.
21:2062022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhang J, Hu C, Zhang R, Xu J, Zhang Y,
Yuan L, Zhang S, Pan S, Cao M, Qin J, et al: The role of
macrophages in gastric cancer. Front Immunol. 14:12821762023.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wu Y, Yi M, Niu M, Mei Q and Wu K:
Myeloid-derived suppressor cells: An emerging target for anticancer
immunotherapy. Mol Cancer. 21:1842022. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ozmen E, Demir TD and Ozcan G:
Cancer-associated fibroblasts: Protagonists of the tumor
microenvironment in gastric cancer. Front Mol Biosci.
11:13401242024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang M, Guan WB, Li JL, Li LX, Wang KZ,
Wang RF and Wang LF: Cancer-associated fibroblasts subtypes and
role in invasion and metastasis of gastric cancer. Neoplasma.
69:1277–1288. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Najafi M, Farhood B and Mortezaee K:
Extracellular matrix (ECM) stiffness and degradation as cancer
drivers. J Cell Biochem. 120:2782–2790. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Khaloozadeh F, Razmara E,
Asgharpour-Babayian F, Fallah A, Ramezani R, Rouhollah F and
Babashah S: Exosomes derived from colorectal cancer cells take part
in activation of stromal fibroblasts through regulating PHLPP
isoforms. EXCLI J. 23:634–654. 2024.PubMed/NCBI
|
|
94
|
Qin Y, Wang F, Ni H, Liu Y, Yin Y, Zhou X,
Gao G, Li Q, Qi X and Li J: Cancer-associated fibroblasts in
gastric cancer affect malignant progression via the CXCL12-CXCR4
axis. J Cancer. 12:3011–3023. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhang Y, Cong X, Li Z and Xue Y: Estrogen
facilitates gastric cancer cell proliferation and invasion through
promoting the secretion of interleukin-6 by cancer-associated
fibroblasts. Int Immunopharmacol. 78:1059372020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Yan Y, Wang LF and Wang RF: Role of
cancer-associated fibroblasts in invasion and metastasis of gastric
cancer. World J Gastroenterol. 21:9717–9726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Dzobo K, Senthebane DA and Dandara C: The
tumor microenvironment in tumorigenesis and therapy resistance
revisited. Cancers (Basel). 15:3762023. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhao Z and Zhu Y: FAP, CD10, and
GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by
inducing EMT and CSC in gastric cancer. BMC Cancer. 23:5072023.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhang H, Deng T, Liu R, Ning T, Yang H,
Liu D, Zhang Q, Lin D, Ge S, Bai M, et al: CAF secreted miR-522
suppresses ferroptosis and promotes acquired chemo-resistance in
gastric cancer. Mol Cancer. 19:432020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhai J, Shen J, Xie G, Wu J, He M, Gao L,
Zhang Y, Yao X and Shen L: Cancer-associated fibroblasts-derived
IL-8 mediates resistance to cisplatin in human gastric cancer.
Cancer Lett. 454:37–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lengyel CG, Hussain S, Seeber A, Jamil
Nidhamalddin S, Trapani D, Habeeb BS, Elfaham E, Mazher SA, Seid F,
Khan SZ, et al: FGFR pathway inhibition in gastric cancer: The
golden era of an old target? Life (Basel). 12:812022.PubMed/NCBI
|
|
102
|
Watabe T and Giesel FL: Fibroblast
activation protein inhibitor PET/CT in gastric cancer. PET Clin.
18:337–344. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Gupta R: Epigenetic regulation and
targeting of ECM for cancer therapy. Am J Physiol Cell Physiol.
322:C762–C768. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Sleeboom JJF, van Tienderen GS,
Schenke-Layland K, van der Laan LJW, Khalil AA and Verstegen MMA:
The extracellular matrix as hallmark of cancer and metastasis: From
biomechanics to therapeutic targets. Sci Transl Med.
16:eadg38402024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Abbaszadegan MR, Mojarrad M and Moghbeli
M: Role of extra cellular proteins in gastric cancer progression
and metastasis: An update. Genes Environ. 42:182020. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Li Q, Zhu CC, Ni B, Zhang ZZ, Jiang SH, Hu
LP, Wang X, Zhang XX, Huang PQ, Yang Q, et al: Lysyl oxidase
promotes liver metastasis of gastric cancer via facilitating the
reciprocal interactions between tumor cells and cancer associated
fibroblasts. EBioMedicine. 49:157–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Laczko R and Csiszar K: Lysyl oxidase
(LOX): Functional contributions to signaling pathways.
Biomolecules. 10:10932020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Gamradt P, De La Fouchardière C and
Hennino A: Stromal protein-mediated immune regulation in digestive
cancers. Cancers (Basel). 13:1462021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ye L, Li Y, Zhang S, Wang J and Lei B:
Exosomes-regulated lipid metabolism in tumorigenesis and cancer
progression. Cytokine Growth Factor Rev. 73:27–39. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Jiang Y, Zhang H, Wang J, Liu Y, Luo T and
Hua H: Targeting extracellular matrix stiffness and
mechanotransducers to improve cancer therapy. J Hematol Oncol.
15:342022. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Li M, Wang Y, Li M, Wu X, Setrerrahmane S
and Xu H: Integrins as attractive targets for cancer therapeutics.
Acta Pharm Sin B. 11:2726–2737. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lugano R, Ramachandran M and Dimberg A:
Tumor angiogenesis: Causes, consequences, challenges and
opportunities. Cell Mol Life Sci. 77:1745–1770. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li P, Zhang H, Chen T, Zhou Y, Yang J and
Zhou J: Cancer-associated fibroblasts promote proliferation,
angiogenesis, metastasis and immunosuppression in gastric cancer.
Matrix Biol. 132:59–71. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Van Cutsem E, de Haas S, Kang YK, Ohtsu A,
Tebbutt NC, Ming Xu J, Peng Yong W, Langer B, Delmar P, Scherer SJ
and Shah MA: Bevacizumab in combination with chemotherapy as
first-line therapy in advanced gastric cancer: A biomarker
evaluation from the AVAGAST randomized phase III trial. J Clin
Oncol. 30:2119–2127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bang YJ, Kang YK, Kang WK, Boku N, Chung
HC, Chen JS, Doi T, Sun Y, Shen L, Qin S, et al: Phase II study of
sunitinib as second-line treatment for advanced gastric cancer.
Invest New Drugs. 29:1449–1458. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
de Visser KE and Joyce JA: The evolving
tumor microenvironment: From cancer initiation to metastatic
outgrowth. Cancer Cell. 41:374–403. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Fang J, Lu Y, Zheng J, Jiang X, Shen H,
Shang X, Lu Y and Fu P: Exploring the crosstalk between endothelial
cells, immune cells, and immune checkpoints in the tumor
microenvironment: New insights and therapeutic implications. Cell
Death Dis. 14:5862023. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Gysler SM and Drapkin R: Tumor
innervation: Peripheral nerves take control of the tumor
microenvironment. J Clin Invest. 131:e1472762021. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Cifuentes L, Camilleri M and Acosta A:
Gastric sensory and motor functions and energy intake in health and
obesity-therapeutic implications. Nutrients. 13:11582021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Serafim Junior V, Fernandes GMM,
Oliveira-Cucolo JG, Pavarino EC and Goloni-Bertollo EM: Role of
Tropomyosin-related kinase B receptor and brain-derived
neurotrophic factor in cancer. Cytokine. 136:1552702020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hayakawa Y, Sakitani K, Konishi M, Asfaha
S, Niikura R, Tomita H, Renz BW, Tailor Y, Macchini M, Middelhoff
M, et al: Nerve growth factor promotes gastric tumorigenesis
through aberrant cholinergic signaling. Cancer Cell. 31:21–34.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Schledwitz A, Sundel MH, Alizadeh M, Hu S,
Xie G and Raufman JP: Differential actions of muscarinic receptor
subtypes in gastric, pancreatic, and colon cancer. Int J Mol Sci.
22:131532021. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Muñoz M and Coveñas R: Involvement of
substance P and the NK-1 receptor in cancer progression. Peptides.
48:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Muñoz M, Rosso M and Coveñas R: The NK-1
receptor antagonist L-732,138 induces apoptosis in human
gastrointestinal cancer cell lines. Pharmacol Rep. 69:696–701.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lan YL, Zou S, Wang W, Chen Q and Zhu Y:
Progress in cancer neuroscience. MedComm (2020). 4:e4312023.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Han X, Liu T, Zhai J, Liu C, Wang W, Nie
C, Wang Q, Zhu X, Zhou H and Tian W: Association between EPHA5
methylation status in peripheral blood leukocytes and the risk and
prognosis of gastric cancer. PeerJ. 10:e137742022. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Niu Q, Zhu J, Yu X, Feng T, Ji H, Li Y,
Zhang W and Hu B: Immune response in H. pylori-associated gastritis
and gastric cancer. Gastroenterol Res Pract. 2020:93425632020.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Jing Y, Xu F, Liang W, Liu J and Zhang L:
Role of regulatory B cells in gastric cancer: Latest evidence and
therapeutics strategies. Int Immunopharmacol. 96:1075812021.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Liu K, Yuan S, Wang C and Zhu H:
Resistance to immune checkpoint inhibitors in gastric cancer. Front
Pharmacol. 14:12853432023. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Yeh ES: Special issue: Cancer metastasis
and therapeutic resistance. Biomedicines. 11:13472023. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Xiao Y and Yu D: Tumor microenvironment as
a therapeutic target in cancer. Pharmacol Ther. 221:1077532021.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Dallavalasa S, Beeraka NM, Basavaraju CG,
Tulimilli SV, Sadhu SP, Rajesh K, Aliev G and Madhunapantula SV:
The role of tumor associated macrophages (TAMs) in cancer
progression, chemoresistance, angiogenesis and metastasis-current
status. Curr Med Chem. 28:8203–8236. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Liao Z, Tan ZW, Zhu P and Tan NS:
Cancer-associated fibroblasts in tumor microenvironment-Accomplices
in tumor malignancy. Cell Immunol. 343:1037292019. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Biagioni A, Peri S, Versienti G, Fiorillo
C, Becatti M, Magnelli L and Papucci L: Gastric cancer
vascularization and the contribution of reactive oxygen species.
Biomolecules. 13:8862023. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Liu K, Wang Y, Wang C, Guo C and Zhang D,
Zhong Y, Yin L, Lu Y, Liu F, Zhang Y and Zhang D: Spatial
transcriptomics of gastric cancer brain metastasis reveals atypical
vasculature strategies with supportive immune profiles.
Gastroenterol Rep (Oxf). 12:goae0672024. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Yuzhalin AE, Lim SY, Kutikhin AG and
Gordon-Weeks AN: Dynamic matrisome: ECM remodeling factors
licensing cancer progression and metastasis. Biochim Biophys Acta
Rev Cancer. 1870:207–228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Fields GB: The rebirth of matrix
metalloproteinase inhibitors: Moving beyond the dogma. Cells.
8:9842019. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Namee NM and O'Driscoll L: Extracellular
vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev
Cancer. 1870:123–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Wang X, Eichhorn PJA and Thiery JP: TGF-β,
EMT, and resistance to anti-cancer treatment. Semin Cancer Biol.
97:1–11. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Li Y, Wang Z, Ajani JA and Song S: Drug
resistance and cancer stem cells. Cell Commun Signal. 19:192021.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Yeldag G, Rice A and Del Río Hernández A:
Chemoresistance and the self-maintaining tumor microenvironment.
Cancers (Basel). 10:4712018. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Ma ES, Wang ZX, Zhu MQ and Zhao J: Immune
evasion mechanisms and therapeutic strategies in gastric cancer.
World J Gastrointest Oncol. 14:216–229. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Guo J, Zhao J, Fu W, Xu Q and Huang D:
Immune Evasion and drug resistance mediated by USP22 in cancer:
Novel targets and mechanisms. Front Immunol. 13:9183142022.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Li J and Stanger BZ: How tumor cell
dedifferentiation drives immune evasion and resistance to
immunotherapy. Cancer Res. 80:4037–4041. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wang H, Ewetse MP, Ma C, Pu W, Xu B, He P,
Wang Y, Zhu J and Chen H: The ‘light knife’ for gastric cancer:
Photodynamic therapy. Pharmaceutics. 15:1012022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Li K, Zhang A, Li X, Zhang H and Zhao L:
Advances in clinical immunotherapy for gastric cancer. Biochim
Biophys Acta Rev Cancer. 1876:1886152021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Wilke H, Muro K, Van Cutsem E, Oh SC,
Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, et
al: Ramucirumab plus paclitaxel versus placebo plus paclitaxel in
patients with previously treated advanced gastric or
gastro-oesophageal junction adenocarcinoma (RAINBOW): A
double-blind, randomised phase 3 trial. Lancet Oncol. 15:1224–1235.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Shitara K, Kadowaki S, Nishina T, Sakai D,
Yoshikawa R, Piao Y, Ozeki A, Inoue K, Gritli I and Muro K: Safety,
pharmacokinetic, and clinical activity profiles of ramucirumab in
combination with three platinum/fluoropyrimidine doublets in
Japanese patients with chemotherapy-naïve metastatic
gastric/gastroesophageal junction cancer. Gastric Cancer.
21:106–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Chen C, Jung A, Yang A, Monroy I, Zhang Z,
Chaurasiya S, Deshpande S, Priceman S, Fong Y, Park AK and Woo Y:
Chimeric antigen receptor-T cell and oncolytic viral therapies for
gastric cancer and peritoneal carcinomatosis of gastric origin:
Path to improving combination strategies. Cancers (Basel).
15:56612023. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Patel TH and Cecchini M: Targeted
therapies in advanced gastric cancer. Curr Treat Options Oncol.
21:702020. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Kwon M, An M, Klempner SJ, Lee H, Kim KM,
Sa JK, Cho HJ, Hong JY, Lee T, Min YW, et al: Determinants of
response and intrinsic resistance to PD-1 blockade in
microsatellite instability-high gastric cancer. Cancer Discov.
11:2168–2185. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Janjigian YY, Kawazoe A, Yañez P, Li N,
Lonardi S, Kolesnik O, Barajas O, Bai Y, Shen L, Tang Y, et al: The
KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive
gastric cancer. Nature. 600:727–730. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Entezam M, Sanaei MJ, Mirzaei Y, Mer AH,
Abdollahpour-Alitappeh M, Azadegan-Dehkordi F and Bagheri N:
Current progress and challenges of immunotherapy in gastric cancer:
A focus on CAR-T cells therapeutic approach. Life Sci.
318:1214592023. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Yu Y, Xu B, Xiang L, Ding T, Wang N, Yu R,
Gu B, Gao L, Maswikiti EP, Wang Y, et al: Photodynamic therapy
improves the outcome of immune checkpoint inhibitors via
remodelling anti-tumour immunity in patients with gastric cancer.
Gastric Cancer. 26:798–813. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Xu B, He P, Wang Y, Wang H, Zhang J, Zhu
J, Pu W and Chen H: PDT for gastric cancer-the view from China.
Photodiagnosis Photodyn Ther. 42:1033662023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhao R, Cui Y, Zheng Y, Li S, Lv J, Wu Q,
Long Y, Wang S, Yao Y, Wei W, et al: Human hyaluronidase PH20
potentiates the antitumor activities of mesothelin-specific CAR-T
cells against gastric cancer. Front Immunol. 12:6604882021.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Zhang X, Liu SS, Ma J and Qu W: Secretory
leukocyte protease inhibitor (SLPI) in cancer pathophysiology:
Mechanisms of action and clinical implications. Pathol Res Pract.
248:1546332023. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Lim NR and Chung WC: Helicobacter
pylori-associated chronic atrophic gastritis and progression of
gastric carcinogenesis. Korean J Gastroenterol. 82:171–179. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Graham DY: Helicobacter pylori update:
Gastric cancer, reliable therapy, and possible benefits.
Gastroenterology. 148:719–731.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Deng R, Zheng H, Cai H, Li M, Shi Y and
Ding S: Effects of helicobacter pylori on tumor microenvironment
and immunotherapy responses. Front Immunol. 13:9234772022.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Guo R and Yang B: Hypoxia-induced LXRα
contributes to the migration and invasion of gastric cancer cells.
Folia Biol (Praha). 67:91–101. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Li S, Cong X, Gao H, Lan X, Li Z, Wang W,
Song S, Wang Y, Li C, Zhang H, et al: Tumor-associated neutrophils
induce EMT by IL-17a to promote migration and invasion in gastric
cancer cells. J Exp Clin Cancer Res. 38:62019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Fu L, Bu L, Yasuda T, Koiwa M, Akiyama T,
Uchihara T, Baba H and Ishimoto T: Gastric cancer stem cells:
Current insights into the immune microenvironment and therapeutic
targets. Biomedicines. 8:72020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Aghlara-Fotovat S, Nash A, Kim B, Krencik
R and Veiseh O: Targeting the extracellular matrix for
immunomodulation: Applications in drug delivery and cell therapies.
Drug Deliv Transl Res. 11:2394–2413. 2021. View Article : Google Scholar : PubMed/NCBI
|
